Insider · CIK 0001780664

RUBINSTEIN JULIE

Reports to the SEC for 1 company · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001780664

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-26	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	President and COO	MExercise/Conversion	−11.9K sh	—	—	165,919
2026-10-26	ADPTAdaptive Biotechnologies CorpS Sale	President and COO	SSale	−3,378 sh	$26.30	−$88.8K	377,802
2026-10-26	ADPTAdaptive Biotechnologies CorpS Sale	President and COO	SSale	−8,503 sh	$25.94	−$221K	381,180
2026-10-26	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	President and COO	MExercise/Conversion	+11.9K sh	$12.14	+$144K	389,683
2026-10-23	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	President and COO	MExercise/Conversion	−11.9K sh	—	—	177,800
2026-10-23	ADPTAdaptive Biotechnologies CorpS Sale	President and COO	SSale	−7,381 sh	$25.28	−$187K	377,802
2026-10-23	ADPTAdaptive Biotechnologies CorpS Sale	President and COO	SSale	−4,500 sh	$24.50	−$110K	385,183
2026-10-23	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	President and COO	MExercise/Conversion	+11.9K sh	$12.14	+$144K	389,683
2026-10-22	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	President and COO	MExercise/Conversion	−11.9K sh	—	—	189,681
2026-10-22	ADPTAdaptive Biotechnologies CorpS Sale	President and COO	SSale	−1,700 sh	$25.29	−$43K	377,802
2026-10-22	ADPTAdaptive Biotechnologies CorpS Sale	President and COO	SSale	−10.2K sh	$24.38	−$248K	379,502
2026-10-22	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	President and COO	MExercise/Conversion	+11.9K sh	$12.14	+$144K	389,683
2026-10-21	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	President and COO	MExercise/Conversion	−11.9K sh	—	—	201,562
2026-10-21	ADPTAdaptive Biotechnologies CorpS Sale	President and COO	SSale	−5,882 sh	$25.57	−$150K	377,802
2026-10-21	ADPTAdaptive Biotechnologies CorpS Sale	President and COO	SSale	−5,999 sh	$25.25	−$151K	383,684
2026-10-21	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	President and COO	MExercise/Conversion	+11.9K sh	$12.14	+$144K	389,683
2026-10-20	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	President and COO	MExercise/Conversion	−11.9K sh	—	—	213,443
2026-10-20	ADPTAdaptive Biotechnologies CorpS Sale	President and COO	SSale	−100 sh	$24.85	−$2,485	377,802
2026-10-20	ADPTAdaptive Biotechnologies CorpS Sale	President and COO	SSale	−11.8K sh	$24.53	−$289K	377,902
2026-10-20	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	President and COO	MExercise/Conversion	+11.9K sh	$12.14	+$144K	389,683
2026-10-19	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	President and COO	MExercise/Conversion	−11.9K sh	—	—	225,324
2026-10-19	ADPTAdaptive Biotechnologies CorpS Sale	President and COO	SSale	−11.9K sh	$24.05	−$286K	377,802
2026-10-19	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	President and COO	MExercise/Conversion	+11.9K sh	$12.14	+$144K	389,683
2026-10-16	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	President and COO	MExercise/Conversion	+11.9K sh	$12.14	+$144K	389,683
2026-10-16	ADPTAdaptive Biotechnologies CorpS Sale	President and COO	SSale	−11.6K sh	$24.21	−$280K	378,102
2026-10-16	ADPTAdaptive Biotechnologies CorpS Sale	President and COO	SSale	−300 sh	$25.45	−$7,635	377,802
2026-10-16	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	President and COO	MExercise/Conversion	−11.9K sh	—	—	237,205
2026-10-15	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	President and COO	MExercise/Conversion	+11.9K sh	$12.14	+$144K	389,683
2026-10-15	ADPTAdaptive Biotechnologies CorpS Sale	President and COO	SSale	−11.9K sh	$25.61	−$304K	377,802
2026-10-15	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	President and COO	MExercise/Conversion	−11.9K sh	—	—	249,086
2026-10-14	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	President and COO	MExercise/Conversion	+11.9K sh	$12.14	+$144K	389,683
2026-10-14	ADPTAdaptive Biotechnologies CorpS Sale	President and COO	SSale	−6,781 sh	$25.57	−$173K	382,902
2026-10-14	ADPTAdaptive Biotechnologies CorpS Sale	President and COO	SSale	−5,100 sh	$25.82	−$132K	377,802
2026-10-14	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	President and COO	MExercise/Conversion	−11.9K sh	—	—	260,967
2026-10-13	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	President and COO	MExercise/Conversion	+11.9K sh	$12.14	+$144K	389,683
2026-10-13	ADPTAdaptive Biotechnologies CorpS Sale	President and COO	SSale	−11.9K sh	$25.50	−$303K	377,802
2026-10-13	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	President and COO	MExercise/Conversion	−11.9K sh	—	—	272,848
2026-10-12	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	President and COO	MExercise/Conversion	+11.9K sh	$12.14	+$144K	389,683
2026-10-12	ADPTAdaptive Biotechnologies CorpS Sale	President and COO	SSale	−9,181 sh	$25.35	−$233K	380,502
2026-10-12	ADPTAdaptive Biotechnologies CorpS Sale	President and COO	SSale	−2,700 sh	$26.07	−$70.4K	377,802
2026-10-12	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	President and COO	MExercise/Conversion	−11.9K sh	—	—	284,729
2026-10-09	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	President and COO	MExercise/Conversion	+11.9K sh	$12.14	+$144K	389,683
2026-10-09	ADPTAdaptive Biotechnologies CorpS Sale	President and COO	SSale	−11.9K sh	$26.41	−$314K	377,802
2026-10-09	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	President and COO	MExercise/Conversion	−11.9K sh	—	—	296,610
2026-10-08	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	President and COO	MExercise/Conversion	+11.9K sh	$12.14	+$144K	389,683
2026-10-08	ADPTAdaptive Biotechnologies CorpS Sale	President and COO	SSale	−11.9K sh	$25.66	−$305K	377,802
2026-10-08	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	President and COO	MExercise/Conversion	−11.9K sh	—	—	308,491
2026-10-07	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	President and COO	MExercise/Conversion	+11.9K sh	$12.14	+$144K	389,683
2026-10-07	ADPTAdaptive Biotechnologies CorpS Sale	President and COO	SSale	−11.9K sh	$26.40	−$314K	377,802
2026-10-07	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	President and COO	MExercise/Conversion	−11.9K sh	—	—	320,372

Recent filings

Accepted (ET)
Oct 264
RUBINSTEIN JULIE0001780664-26-000045
SEC(opens sec.gov)
Oct 214
RUBINSTEIN JULIE0001780664-26-000043
SEC(opens sec.gov)

Companies

Adaptive Biotechnologies CorpPresident and COOADPT

Address

C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1165 EASTLAKE AVENUE EAST

SEATTLE, WA, 98109